Cart
sales@molnova.com
Sodium butanoate
CAS No. 156-54-7
Sodium butanoate( Butyric Acid )
Catalog No. M12232 CAS No. 156-54-7
Sodium Butyrate(Butanoic acid sodium salt) has been reported to cause hyperacetylation of histones due to its role as a histone deacetylase (HDAC) inhibitor (IC50 values are 0.3, 0.4, 0.3, mM for HDAC1, 2 and 7 respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 200MG | 36 | In Stock |
|
| 500MG | 45 | In Stock |
|
| 1G | 48 | In Stock |
|
Biological Information
-
Product NameSodium butanoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSodium Butyrate(Butanoic acid sodium salt) has been reported to cause hyperacetylation of histones due to its role as a histone deacetylase (HDAC) inhibitor (IC50 values are 0.3, 0.4, 0.3, mM for HDAC1, 2 and 7 respectively).
-
DescriptionSodium Butyrate(Butanoic acid sodium salt) has been reported to cause hyperacetylation of histones due to its role as a histone deacetylase (HDAC) inhibitor (IC50 values are 0.3, 0.4, 0.3, mM for HDAC1, 2 and 7 respectively).
-
In Vitro——
-
In Vivo——
-
SynonymsButyric Acid
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1 receptor
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number156-54-7
-
Formula Weight110.09
-
Molecular FormulaC4H7NaO2
-
Purity>98% (HPLC)
-
SolubilityWater: 22 mg/mL (199.83 mM)
-
SMILES[Na+].CCCC([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Archer SY, et al. Proc Natl Acad Sci U S A, 1998, 95(12), 6791-6796.
molnova catalog
related products
-
Lodoxamide trometham...
Lodoxamide tromethamine is a mast cell stabilizer with anti-allergic properties and can be used in studies about the treatment of asthma and allergic conjunctivitis.
-
polygalaxanthone III
Polygalaxanthone III can significantly inhibit chlorzoxazone 6-hydroxylation catalyzed by CYP2E1.
-
PF-03654764
PF-03654764 (PF 3654764) is a potent, selective, orally bioactive antagonist of H3 receptor with Ki of 1.4 nM.
